Pirtobrutinib for untreated chronic lymphocytic leukaemia or small lymphocytic lymphoma [ID6397]

  • In development
  • GID-TA11501
  • Expected publication date: TBC

Please note that following a request from the company, the appraisal is now paused. The committee meeting scheduled for 6 October 2026 will not be going ahead. We expect to provide an update on expected timelines by Q4 2026.

Please note that following a request from the company, the appraisal is now paused. The committee meeting scheduled for 6 October 2026 will not be going ahead. We expect to provide an update on expected timelines by Q4 2026.